BlackRock’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

BlackRock’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-468	Closed	-$35K	–	3597
2015 Q3	$35K	Sell	468 -152	-25%	-$11.4K	﹤0.01%	2084
2015 Q2	$47K	Buy	620 +170	+38%	+$9.11K	﹤0.01%	2002
2015 Q1	$23K	Hold	450	–	–	﹤0.01%	2312
2014 Q4	$16K	Buy	450 +44	+11%	+$1.53K	﹤0.01%	2498
2014 Q3	$13K	Hold	406	–	–	﹤0.01%	2584
2014 Q2	$16K	Buy	406 +132	+48%	+$4.61K	﹤0.01%	2521
2014 Q1	$11K	Hold	274	–	–	﹤0.01%	2685
2013 Q4	$10K	Hold	274	–	–	﹤0.01%	2754
2013 Q3	$12K	Hold	274	–	–	﹤0.01%	2562
2013 Q2	$7K	Buy	+274	New	+$6.27K	﹤0.01%	2913

BlackRock's KYTH Position: Q4 2015 in Review

BlackRock sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 468 shares — an estimated $35K sold.

BlackRock first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $47K in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

BlackRock reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
BlackRock sold 468 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $35K.
BlackRock first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
BlackRock's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $47K in Q2 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on BlackRock's 13F filing for Q4 2015, filed 11 Feb 2016.